Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,643 public trials 304 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

NCT00252148

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Rockefeller University Hospital New York, United States

University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults

NCT00249106

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Rockefeller University Hospital New York, United States

University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan

NCT01467349

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Infectious Diseases Department Milan, Italy

View Trial Details

Completed

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

NCT00902824

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: St Stephen's Centre Chelsea and Westminster Hospital London, United Kingdom

View Trial Details

Completed

Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines

NCT01264445

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Kenya AIDS Vaccine Initiative Nairobi, Kenya

Uganda Virus Research Institute-IAVI Entebbe, Uganda

Medical Research Council Masaka, Uganda

Zambia-Emory HIV Research Project Lusaka, Zambia

View Trial Details

Completed

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

NCT00918840

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: IRCCS Policlinico S. Matteo Pavia, Italy

View Trial Details

Completed

Role of HIV on Glutathione Synthesis and Oxidative Stress

NCT01355198

Conditions: Blood-Borne Infections, Communicable Diseases, Erythrocyte Glutathione Deficiency, +13 more
Locations: Baylor GCRC Houston, Texas, United States

View Trial Details

Completed

HIV Screening in the Emergency Department Setting

NCT00667186

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: University of Cincinnati Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

NCT01289951

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: Hospital Universitario Ramón y Cajal. Madrid, Spain

View Trial Details

Completed

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

NCT00807443

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Hospital Universitario Ramon Y Cajal Madrid, Spain

View Trial Details

Lentivirus Infections

Lentivirus Infections trial results

Related conditions